Concall Analysis

Management Guidance

-->Total revenue for the year was 2811.7 crores as against 2043.8 during last year. A growth of around 37.6%.(if you had refereed my last concall these figures were estimated by the management itself).

-->Net profit was 715.3 cores as compared to 170 crores last year.

-->Increase in revenue and profits was due to increase in growth in the US , Canada and Brazil region.

-->In the 4th quarter the revenue was 926.9 crores as compared to 610.6 crores.

-->Profit was 275.8 crores as against loss of 50.5 crores in the last quarter.

-->The company had launched 11 products in the domestic segment this year.

-->Management feels like they will grow by 8-10% next y ear

-->They are still looking out for acquisition. They have been saying this for past 2 years but not delivered, management admits this and hopes that they will deliver this year.

-->Company has bought back 2% of their shares through buyback.

-->Management believes that the future of the business are their subsidiaries.

-->They are setting up a new subsidiary in Colombia and Indonesia.

-->They are also looking to buy an asset in the UK.

-->Management intimates that?they will spend extremely high on R&D.

-->Agro sales happen only in June and September during the kharif season.

-->Gross margin decline this quarter was due to one time INR 50 crores charge to their supplier's as a part of pre-agreement.

-->Intangible assets of INR 50 crores was due to goodwill in acquisition of DASH.

-->8% of revenue is what company has spent on R & D this year.

-->Their subsidiaries are rising due to new launches, new approvals and few tender orders.

-->Apixaban has been their star product in Brazil.

-->In agri business CTPR was the only contribution and now they are working? towards for 6,7 products.

Terminologies:

Pronged strategy: It refers to a plan that attacks a goal from multiple directions.

Contract Development and Manufacturing Organization (CDMO): It is a company that provides a wide range of services to pharmaceutical and biotechnology companies. These services can include everything from drug development and formulation to manufacturing, packaging, and distribution.

Medical Terminologies:

Olaparib: It is a medication sold under the brand name Lynparza. It is a targeted therapy used to treat certain types of cancer, including ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Zydelig: It is a brand name for the medication idelalisib, a prescription medication used to treat adults with chronic lymphocytic leukemia.

Tracleer: It is a brand name medication that contains the active ingredient bosentan. It's used to treat pulmonary arterial hypertension (PAH), which is a condition that causes high blood pressure in the lungs.

Idelalisib: It is a medication used to treat certain types of blood cancers.

Apixaban: It is sold under the brand name Eliquis, is a medication used to treat and prevent blood clots.

?